Identification and Development of Therapeutics for COVID-19
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
[HTML][HTML] Identification and Development of Therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee… - mSystems, 2021 - ncbi.nlm.nih.gov
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
Identification and Development of Therapeutics for COVID-19
HM Rando, W Nils, G Soumita, AJ Lee, AA Dattoli… - …, 2021 - search.proquest.com
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
Identification and development of therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee, AA Dattoli… - mSystems, 2021 - lup.lub.lu.se
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
Identification and Development of Therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee, AA Dattoli… - mSystems, 2021 - cir.nii.ac.jp
抄録< jats: p> The COVID-19 pandemic is a rapidly evolving crisis. With the worldwide
scientific community shifting focus onto the SARS-CoV-2 virus and COVID-19, a large …
scientific community shifting focus onto the SARS-CoV-2 virus and COVID-19, a large …
[PDF][PDF] Identification and Development of Therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee, AA Dattoli… - 2021 - researchgate.net
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
Identification and Development of Therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee… - arXiv preprint arXiv …, 2021 - arxiv.org
After emerging in China in late 2019, the novel Severe acute respiratory syndrome-like
coronavirus 2 (SARS-CoV-2) spread worldwide and as of early 2021, continues to …
coronavirus 2 (SARS-CoV-2) spread worldwide and as of early 2021, continues to …
Identification and Development of Therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee… - …, 2021 - pubmed.ncbi.nlm.nih.gov
After emerging in China in late 2019, the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a …
Identification and Development of Therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee… - arXiv e …, 2021 - ui.adsabs.harvard.edu
After emerging in China in late 2019, the novel Severe acute respiratory syndrome-like
coronavirus 2 (SARS-CoV-2) spread worldwide and as of early 2021, continues to …
coronavirus 2 (SARS-CoV-2) spread worldwide and as of early 2021, continues to …
[HTML][HTML] Identification and Development of Therapeutics for COVID-19
HM Rando, N Wellhausen, S Ghosh, AJ Lee, AA Dattoli… - 2021 - europepmc.org
After emerging in China in late 2019, the novel coronavirus SARS-CoV-2 spread worldwide
and as of mid-2021 remains a significant threat globally. Only a few coronaviruses are …
and as of mid-2021 remains a significant threat globally. Only a few coronaviruses are …